Medicinal inorganic chemistry offers additional opportunities for the design of therapeutic
agents not accessible to organic compounds. 1− 3 The wide range of coordination numbers …

Cancer can be defined as an irregular functioning of the cell cycle that results in a
progressive loss of cell differentiation and uncontrolled cell growth. Moreover, despite …

Heterocyclic compounds are foundational in drug discovery, constituting the core structure of
approximately 80% of pharmaceuticals. Benzimidazole, in particular, emerges as a critical …

Sixteen novel mononuclear CuII, CoII, ZnII, and NiII complexes of the biologically active
ligand clotrimazole (clotri) of the forms [M (clotri) 2Cl2]· nH2O (1–4),[M (clotri) 2Br2]· nH2O (5 …

Eighteen new cobalt (II) or zinc (II) complexes of benzimidazole bearing 1-benzyl and 2-
phenyl moieties were synthesized from the reaction of appropriate benzimidazole ligands …

Coordination compounds with cobalt (II), nickel (II), copper (II) and zinc (II) and the ligand 2,
6-bis (2, 6-diethylphenyliminomethyl) pyridine (L) were synthesized and fully characterized …

Complexes of cobalt (II) chloride with 1-propargylimidazole, 1-propargyl-2-methylimidazole,
and 1-propargylbenzimidazole ligands were synthesized and studied by FTIR spectroscopy …

A series of five coordinated, doubly halo bridged Cu (II) complexes [Cu 2 (μ-X) 2 (Ln) 2×
2](X= Cl and Br; n= 1, 2 and 3), CuL1Cl, CuL1Br, CuL2Cl, CuL2Br, CuL3Cl and CuL3Br …

DNA interactions of anticancer mononuclear Cu2+, Co2+, Zn2+, and Ni2+ complexes with
the biologically active ligand clotrimazole (clotri) are reported. To fully characterize DNA …

The interaction of imidazole with a [Cu (acac) 2] complex was studied using electron
paramagnetic resonance (EPR), electron nuclear double resonance (ENDOR), hyperfine …